Video
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Viridian Therapeutics announces positive long-term durability data for veligrotug for the treatment of active thyroid eye disease
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Astigmatism in Hong Kong children increased substantially following COVID-19 era restrictions
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Therini Bio raises $39 million in a Series A extension financing
Sylentis releases topline results from phase 2a of SYL1801